This week, we're reading about formulary exclusions, the cost of the Medicare Advantage program to the federal government, and a handful of pharmacy openings.
- Endpoints News: Proposed FDA budget aligns Makary, Trump behind rivaling China biotech
- Forbes: Thus Far, Most Favored Nation Drug Prices Have Had Little Impact On Consumers
- Endpoints News: Novo claims that its obesity pill is better than Lilly's. Only a head-to-head trial can prove it
- Healthcare Brew: Medicare Advantage may cost the government $84b more than traditional in 2025
- Becker's Hospital Review: PBM formulary exclusions top 600 drugs amid pricing shift
- Health Populi: Past is Prologue as CVS Returns to Its "CVS Pharmacy" Roots – What it Means for Health Consumers and Retail Health (with a nod to Colruyt Group in Belgium)
- Mississippi Today: What lived and died in the 2026 Mississippi legislative session
- Elizabethton Star: Crowe pushes back on ‘misleading' ad over drug pricing bill
- The Beacon: Kansas bill aims to regulate pharmacy benefit managers, the middlemen in prescription drug pricing
- Washington County Journal: Pharmacy Opens in Salem Family Health
- New Jersey Business Magazine: Galenus Precision Pharmacy Celebrates Mt. Laurel Grand Opening
- CNY Central: 24/7 pharmacy highlights need for medication access on holidays
NCPA
